Capital BlueCross MA

Contract: H5216 · Plan type: HMO

This data is for informational purposes only and does not constitute medical, financial, or insurance advice. Contact CMS or your plan for coverage decisions. Data from CMS OIG and KFF Medicare Advantage analysis.

Capital BlueCross MA operates Medicare Advantage contract H5216 as a HMO plan, one of hundreds of MA organizations whose prior authorization and claim-denial behavior is tracked through CMS Office of Inspector General audits and the KFF Medicare Advantage analysis. In the most recent reporting window, Capital BlueCross MA processed 95,000 prior authorization requests, approving 88,540 and denying 6,460 — a denial rate of 6.8%. Prior authorization is the process by which Medicare Advantage plans require plan-level approval before covering specific services, medications, or procedures — a workflow that does not exist in traditional fee-for-service Medicare.

Of the denials issued by Capital BlueCross MA, 969 were appealed by beneficiaries or providers, and 669 of those appeals were overturned — an overturn rate of 69.0%. A high overturn rate is meaningful because the CMS Office of Inspector General flagged it as a sign that initial denials may have been issued incorrectly or based on internal clinical criteria stricter than traditional Medicare's coverage rules. When an appeal reverses a denial, the plan ultimately pays for the care it initially refused, which suggests the original denial was not supported when reviewed more carefully. For Capital BlueCross MA specifically, more than half of appealed denials are overturned, meaning persistence pays off for beneficiaries.

Practical takeaway for beneficiaries enrolled in or considering Capital BlueCross MA: if you receive a prior authorization denial, you have formal appeal rights under CMS Medicare Advantage rules — first through the plan itself, then to an independent review entity, and further through administrative law judges if needed. Do not abandon the appeal because the plan's first decision was unfavorable; the nationwide overturn pattern strongly suggests that appealing is often worthwhile. Data here reflects aggregate plan behavior, not individual case outcomes — your specific denial will depend on the service requested, clinical documentation, and CMS national coverage determinations. This page is informational only and does not constitute medical, financial, or insurance advice. Consult your plan documents, CMS.gov, or a State Health Insurance Assistance Program (SHIP) counselor for guidance specific to your situation.

Prior Authorization Scorecard

PA Requests
95,000
PA Denial Rate
6.8%
Appeals Filed
969
Appeal Overturn Rate
69.0%

Detailed Metrics

Metric Value
Prior Authorization Requests 95,000
PA Approved 88,540
PA Denied 6,460
Appeals Filed 969
Appeals Overturned 669
Source: CMS Office of Inspector General OEI-09-22-00380; KFF 2023 Medicare Advantage analysis.
What does the overturn rate mean? When 69% of denied PA requests are overturned on appeal, it suggests that a significant portion of initial denials may have been inappropriate. If your claim is denied, you have the right to appeal.
Data: CMS OIG OEI-09-22-00380 and KFF 2023 Medicare Advantage analysis. Not affiliated with CMS. ← All MA plans

Related to Capital BlueCross MA

Primary data: U.S. Department of Health & Human Services, Office of Inspector General — Medicare Advantage Encounter Data (Report OEI-09-22-00380, 2024). Secondary data: Kaiser Family Foundation 2023 Medicare Advantage Prior Authorization analysis. Methodology and editorial review by PlainInsurer Editorial — see methodology.